I think so too. Momentum and interest will start to build with each significant news event like RP submission yesterday. I think we will start to see a lot of significant updates leading up to uplist and Lympro revenue. I personally think LPC is holding the price down best they can to accumulate shares under .10. However, at some point with continued news, volume will limit their ability to do it. Also, at some point, it doesn't make sense for them to hold it down. They want the share price as high as possible going into an uplist too! They don't want their shares cut by a factor of 20. They are here to make money just like us. Very soon this will run and run hard.